Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 732

1.

Review of adjunctive dexmedetomidine in the management of severe acute alcohol withdrawal syndrome.

Wong A, Smithburger PL, Kane-Gill SL.

Am J Drug Alcohol Abuse. 2015 Sep;41(5):382-91. doi: 10.3109/00952990.2015.1058390.

PMID:
26337198
2.

Commonalities and Differences Across Substance Use Disorders: Phenomenological and Epidemiological Aspects.

Shmulewitz D, Greene ER, Hasin D.

Alcohol Clin Exp Res. 2015 Sep 1. doi: 10.1111/acer.12838. [Epub ahead of print]

PMID:
26332166
3.

Efficacy of Medications Approved for the Treatment of Alcohol Dependence and Alcohol Withdrawal Syndrome in Female Patients: A Descriptive Review.

Agabio R, Pani PP, Preti A, Gessa GL, Franconi F.

Eur Addict Res. 2016;22(1):1-16. doi: 10.1159/000433579. Epub 2015 Aug 29.

4.

Symptom-Triggered vs. Fixed-Dosing Management of Alcohol Withdrawal Syndrome.

Skinner RT.

Medsurg Nurs. 2014 Sep-Oct;23(5):307-15, 329.

PMID:
26292436
5.

Alcohol liver disease: A review of current therapeutic approaches to achieve long-term abstinence.

García ML, Blasco-Algora S, Fernández-Rodríguez CM.

World J Gastroenterol. 2015 Jul 28;21(28):8516-26. doi: 10.3748/wjg.v21.i28.8516. Review.

6.

Review of adjunctive dexmedetomidine in the management of severe acute alcohol withdrawal syndrome.

Wong A, Smithburger PL, Kane-Gill SL.

Am J Drug Alcohol Abuse. 2015 Jul 30:1-10. [Epub ahead of print]

PMID:
26225811
7.

Management of benzodiazepine-resistant alcohol withdrawal across a healthcare system: Benzodiazepine dose-escalation with or without propofol.

Wong A, Benedict NJ, Lohr BR, Pizon AF, Kane-Gill SL.

Drug Alcohol Depend. 2015 Sep 1;154:296-9. doi: 10.1016/j.drugalcdep.2015.07.005. Epub 2015 Jul 16.

PMID:
26205315
8.

[GABAB receptor as therapeutic target for drug addiction: from baclofen to positive allosteric modulators].

Agabio R, Colombo G.

Psychiatr Pol. 2015 Mar-Apr;49(2):215-23. doi: 10.12740/PP/33911. Review. Polish.

9.

The Role of Gabapentin in the Management of Alcohol Withdrawal and Dependence.

Leung JG, Hall-Flavin D, Nelson S, Schmidt KA, Schak KM.

Ann Pharmacother. 2015 Aug;49(8):897-906. doi: 10.1177/1060028015585849. Epub 2015 May 12. Review.

PMID:
25969570
10.

Topiramate in Alcohol Use Disorders: Review and Update.

Guglielmo R, Martinotti G, Quatrale M, Ioime L, Kadilli I, Di Nicola M, Janiri L.

CNS Drugs. 2015 May;29(5):383-95. doi: 10.1007/s40263-015-0244-0.

PMID:
25899459
11.

Anticonvulsants for the treatment of alcohol withdrawal syndrome and alcohol use disorders.

Hammond CJ, Niciu MJ, Drew S, Arias AJ.

CNS Drugs. 2015 Apr;29(4):293-311. doi: 10.1007/s40263-015-0240-4.

PMID:
25895020
12.

Baclofen for alcohol withdrawal.

Liu J, Wang LN.

Cochrane Database Syst Rev. 2015 Apr 3;4:CD008502. doi: 10.1002/14651858.CD008502.pub4.

PMID:
25836263
13.

[Craving as a core symptom in substance use disorders: epidemiology, neurobiological substrates and clinical relevance].

Morissette A, Ouellet-Plamondon C, Jutras-Aswad D.

Sante Ment Que. 2014 Fall;39(2):21-37. French.

PMID:
25590542
14.

Inpatient alcohol withdrawal syndrome.

Monte-Secades R, Rabuñal-Rey R, Guerrero-Sande H.

Rev Clin Esp. 2015 Mar;215(2):107-116. doi: 10.1016/j.rce.2014.11.013. Epub 2015 Jan 2. English, Spanish.

PMID:
25559647
15.

[Consequences of tobacco, cocaine and cannabis consumption during pregnancy on the pregnancy itself, on the newborn and on child development: A review].

Lamy S, Laqueille X, Thibaut F.

Encephale. 2015 Jun;41 Suppl 1:S13-20. doi: 10.1016/j.encep.2014.08.012. Epub 2014 Oct 28. French.

PMID:
25439854
16.

Postdependent state in rats as a model for medication development in alcoholism.

Meinhardt MW, Sommer WH.

Addict Biol. 2015 Jan;20(1):1-21. doi: 10.1111/adb.12187. Epub 2014 Nov 17. Review.

PMID:
25403107
17.

Predictors of severe alcohol withdrawal syndrome: a systematic review and meta-analysis.

Goodson CM, Clark BJ, Douglas IS.

Alcohol Clin Exp Res. 2014 Oct;38(10):2664-77. doi: 10.1111/acer.12529. Review.

PMID:
25346507
18.

Evaluation of adjunctive ketamine to benzodiazepines for management of alcohol withdrawal syndrome.

Wong A, Benedict NJ, Armahizer MJ, Kane-Gill SL.

Ann Pharmacother. 2015 Jan;49(1):14-9. doi: 10.1177/1060028014555859. Epub 2014 Oct 16.

PMID:
25325907
19.

[Benefits of specialized centers for the treatment of addictive disorders].

Soravia L, Allemann P.

Ther Umsch. 2014 Oct;71(10):622-5. doi: 10.1024/0040-5930/a000602. Review. German.

PMID:
25257117
20.

Levetiracetam as adjunctive therapy for acute alcohol withdrawal syndrome in hospitalized patients.

Youland KM, Miller RF, Mahoney LJ, Borgert AJ, Gundrum JD.

J Clin Psychopharmacol. 2014 Dec;34(6):704-8. doi: 10.1097/JCP.0000000000000209.

PMID:
25144138
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk